103 related articles for article (PubMed ID: 19220410)
1. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A.
Yamagata A; Ito K; Suzuki T; Dohmae N; Terada T; Shirouzu M
Nat Commun; 2024 Apr; 15(1):3027. PubMed ID: 38637505
[TBL] [Abstract][Full Text] [Related]
3. Synaptic vesicle protein 2A mitigates parthanatos via apoptosis-inducing factor in a rat model of pharmacoresistant epilepsy.
Li C; Wang Z; Ren M; Ren S; Wu G; Wang L
CNS Neurosci Ther; 2024 May; 30(5):e14778. PubMed ID: 38801174
[TBL] [Abstract][Full Text] [Related]
4. Decreased Synaptic Vesicle Glycoprotein 2A Binding in the Human Postmortem Essential Tremor Cerebellum: Evidence of Reduction in Synaptic Density.
Yang Y; Zheng C; Chen B; Hernandez NC; Faust PL; Cai Z; Louis ED; Matuskey D
Cerebellum; 2024 Jun; 23(3):1053-1060. PubMed ID: 37783917
[TBL] [Abstract][Full Text] [Related]
5. SV2A: more than just a new target for AEDs.
Pitkänen A
Epilepsy Curr; 2005; 5(1):14-6. PubMed ID: 16059448
[No Abstract] [Full Text] [Related]
6. An Epilepsy-Associated SV2A Mutation Disrupts Synaptotagmin-1 Expression and Activity-Dependent Trafficking.
Harper CB; Small C; Davenport EC; Low DW; Smillie KJ; Martínez-Mármol R; Meunier FA; Cousin MA
J Neurosci; 2020 Jun; 40(23):4586-4595. PubMed ID: 32341095
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a New Mouse Model to Investigate the Role of SV2A in Epilepsy.
Menten-Dedoyart C; Serrano Navacerrada ME; Bartholome O; Sánchez Gil J; Neirinckx V; Wislet S; Becker G; Plenevaux A; Van den Ackerveken P; Rogister B
PLoS One; 2016; 11(11):e0166525. PubMed ID: 27861538
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Differential Expression of Synaptic Vesicle Protein 2A in the Adult Rat Brain.
Mendoza-Torreblanca JG; García-Cruz ME; Sánchez-Cruz I; Gomez-Gonzalez B; Juárez-Méndez S; Gómez-Lira G
Neuroscience; 2019 Nov; 419():108-120. PubMed ID: 31520710
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of SV2A in hippocampal glutamatergic and GABAergic terminals during postnatal development.
Vanoye-Carlo A; Gómez-Lira G
Brain Res; 2019 Jul; 1715():73-83. PubMed ID: 30905653
[TBL] [Abstract][Full Text] [Related]
10. [Function of synaptic vesicle protein 2A (SV2A) as a novel therapeutic target for epilepsy].
Tokudome K; Shimizu S; Serikawa T; Ohno Y
Nihon Yakurigaku Zasshi; 2018; 152(6):275-280. PubMed ID: 30531097
[TBL] [Abstract][Full Text] [Related]
11. Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission.
Tokudome K; Okumura T; Shimizu S; Mashimo T; Takizawa A; Serikawa T; Terada R; Ishihara S; Kunisawa N; Sasa M; Ohno Y
Sci Rep; 2016 Jun; 6():27420. PubMed ID: 27265781
[TBL] [Abstract][Full Text] [Related]
12. Expression of SV2 isoforms during rodent brain development.
Crèvecœur J; Foerch P; Doupagne M; Thielen C; Vandenplas C; Moonen G; Deprez M; Rogister B
BMC Neurosci; 2013 Aug; 14():87. PubMed ID: 23937191
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of synaptic vesicle protein 2 (SV2) isoforms.
Bajjalieh SM; Frantz GD; Weimann JM; McConnell SK; Scheller RH
J Neurosci; 1994 Sep; 14(9):5223-35. PubMed ID: 8083732
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex.
Halff EF; Cotel MC; Natesan S; McQuade R; Ottley CJ; Srivastava DP; Howes OD; Vernon AC
Behav Brain Res; 2021 May; 405():113203. PubMed ID: 33636238
[TBL] [Abstract][Full Text] [Related]
15. Cross-linking mass spectrometry uncovers protein interactions and functional assemblies in synaptic vesicle membranes.
Wittig S; Ganzella M; Barth M; Kostmann S; Riedel D; Pérez-Lara Á; Jahn R; Schmidt C
Nat Commun; 2021 Feb; 12(1):858. PubMed ID: 33558502
[TBL] [Abstract][Full Text] [Related]
16. A
Calame DG; Herman I; Riviello JJ
Epilepsy Behav Rep; 2021; 15():100425. PubMed ID: 33554103
[No Abstract] [Full Text] [Related]
17. The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance.
Stout KA; Dunn AR; Hoffman C; Miller GW
ACS Chem Neurosci; 2019 Sep; 10(9):3927-3938. PubMed ID: 31394034
[TBL] [Abstract][Full Text] [Related]
18. Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events.
Romoli M; Mandarano M; Romozzi M; Eusebi P; Bedetti C; Nardi Cesarini E; Verzina A; Calvello C; Loreti E; Sidoni A; Giovenali P; Calabresi P; Costa C
J Neurol; 2019 Sep; 266(9):2273-2276. PubMed ID: 31168673
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis.
Ohno Y; Tokudome K
CNS Neurol Disord Drug Targets; 2017; 16(4):463-471. PubMed ID: 28393712
[TBL] [Abstract][Full Text] [Related]
20. Orbitofrontal Neuroadaptations and Cross-Species Synaptic Biomarkers in Heavy-Drinking Macaques.
Nimitvilai S; Uys JD; Woodward JJ; Randall PK; Ball LE; Williams RW; Jones BC; Lu L; Grant KA; Mulholland PJ
J Neurosci; 2017 Mar; 37(13):3646-3660. PubMed ID: 28270566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
